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Abstract
Objective
To investigate trends in the incidence of imported malaria in the UK between 2005 and 2016.
Design
Analysis of longitudinal electronic health records (EHRs) in The Health Improvement Net-
work (THIN) primary care database.
Setting
UK primary care
Participants
In total, we examined 12,349,003 individuals aged 0 to 99 years.
Outcome measure
The rate of malaria recordings in THIN was calculated per year between 2005 and 2016.
Rate ratios exploring differences by age, sex, location of general practice, socioeconomic
status and ethnicity were estimated using multivariable Poisson regression.
Results
A total of 1,474 individuals with a first diagnosis of malaria were identified in THIN between
2005 and 2016. The incidence of recorded malaria followed a decreasing trend dropping
from a rate of 3.33 in 2005 to 1.36 cases per 100,000 person years at risk in 2016. Multivari-
able Poisson regression showed that adults of working age (20 to 69 years), men, those reg-
istered with a general practice in London, higher social deprivation and non-white ethnicity
were associated with higher rates of malaria recordings.
Conclusion
There has been a decrease in the number of malaria recordings in UK primary care over the
past decade. This decrease exceeds the rate of decline reported in national surveillance
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data; however there are similar associations with age, sex and deprivation. Improved geo-
graphic information on the distribution of cases and the potential for automation of case
identification suggests that EHRs could provide a complementary role for investigating
malaria trends over time.
Introduction
Globally, malaria affected 216 million individuals in 2016 and resulted in 445,000 deaths [1].
Amongst non-endemic countries, the UK has one of the highest numbers of imported malaria
in Europe with around 1500 cases a year [2]. Despite a decreasing trend in the overall global
number of cases, it remains the most common imported infection in returning ill travellers in
Europe [3].
In the UK, malaria is a notifiable disease and information on trends over time is usually
obtained from passive surveillance data on imported cases from the Malaria Reference Labora-
tory (MRL), supplemented more recently with cases reported to the Public Health England
(PHE) case management database (HPzone) [2, 4]. Reports on cases are completed by clini-
cians and laboratory staff with information on patient demographics, reason for travel, area
and duration of travel, and chemoprophylaxis use [5]. This surveillance method is associated
with underreporting since not all cases who seek healthcare are notified. A capture recapture
study estimated that only 56% of cases were captured by the MRL surveillance system [6],
with similar levels of underreporting in other European notification based surveillance systems
[7–9].
Use of electronic health records (EHRs) may provide a complementary method of explor-
ing trends in malaria diagnoses over time. Although they have limitations, EHRs have been
widely used for observational research and several studies have used them for exploring trends
in the incidence of illnesses over time [10–13]. Data collection at the time of recording a
malaria diagnosis in primary care can result in the inclusion of unreported cases in the analysis
as it forgoes the added step of notification. Furthermore, it can provide insight into the num-
ber of cases seen in this setting.
Our aims were to investigate the incidence of imported malaria in the UK between 2005
and 2016 using The Health Improvement Network (THIN) Primary care database; to explore
the variation in incidence by age, sex, UK region, socioeconomic status and ethnicity; and to
compare the characteristics of cases identified in THIN to those identified through passive
surveillance.
Methods
Data source
Relevant data were extracted from THIN. THIN contains anonymised EHRs of around 12 mil-
lion patients attending 693 general practices participating in the network [14]. It has coverage
of around 6% of the UK population and has been shown to be broadly representative of the
UK population in terms of demographics and prevalence of major conditions [15]. Data in
THIN are collected routinely from consultations in general practice and consist of information
on individual patient characteristics, medical information such as symptoms and diagnoses of
disease, investigations ordered and medication prescribed. Data are coded using Read codes, a
standard vocabulary list clinician’s use to record medical information; and drug codes, based
on the British National Formulary classifications for medication.
Imported malaria in the UK
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Study population
General practices that contributed data to THIN between January 2005 and December 2016
were used for this study. The quality of the data included was assessed using the acceptable
computer usage (ACU) dates [16] and the acceptable mortality recording (AMR) dates [17].
The ACU date refers to the date when general practices use their computer systems adequately
for recording clinical data. In THIN, this was defined as the date where at least one medical
record, one additional health data (AHD) record and two therapy records are consistently
recorded per patient per year[16]. The AMR date refers to the date from which the mortality
recordings of a general practice are deemed complete. In THIN, this was defined as the date
the mortality recordings within the general practice was similar to what the expected mortality
would be in the general population using the Office for National Statistics data, taking into
account the characteristics of the patients within that practice [17]. Practices were included
after the latter of the ACU and AMR date. Additionally, information on postcode linked socio-
economic indices (Townsend Score) was not available for 17 practices and they were excluded
from the analysis.
Participants
All individuals aged 0–99 years that were registered with a general practice contributing data
between 2005 and 2016 were included in the analysis.
Case definition. Cases of malaria in primary care may be indicated by diagnostic codes,
or a combination of investigation and treatment codes. An algorithm was developed to identify
individuals diagnosed with malaria within THIN based on having any of the following records
(Fig 1):
• A diagnostic Read code for malaria:
A Read code list indicating a diagnosis of malaria was developed (S1 Table). Those with a
malaria diagnostic Read code within their medical records were considered to have a diagno-
sis of malaria. The date that malaria was first recorded was considered the index date of
diagnosis.
• A code for malaria investigation followed by treatment for malaria within 60 days:
In order to capture potential cases that did not have a diagnostic Read code for malaria,
those with an AHD code or Read code for malaria specific investigations were identified
(S1 Table). In records where a laboratory test is ordered with no result reported in THIN, it
was assumed that the individual had a diagnosis of malaria if an antimalarial was prescribed
within two months after the date the test was ordered. The antimalarials prescribed were
identified using a drug code list developed based on chapter 5.4.1 of the British National For-
mulary (BNF) (S1 Table) [18]. Although some of these medications can be used for prophy-
laxis, the preceding indication for ordering the malaria specific investigation makes this
unlikely. The date the antimalarial was prescribed was considered the index date of diagnosis
in those who were investigated for malaria.
• A prescription for artemesinin-based combination therapy (ACT).
Artemesinin-based combination therapy is the recommended treatment for those with P.
falciparum infection and for non-falciparum malaria if the area of infection is known to have
chloroquine resistance [19]. The drug codes in THIN were searched to identify all ACTs
recorded in the database and only artemether–lumefantrine was identified. Artemether–
lumefantrine is the drug of choice for treating uncomplicated P. falciparum and is licensed
solely for the treatment of malaria [18]. It was assumed that the individual had a diagnosis of
Imported malaria in the UK
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malaria if they received a prescription for artemether-lumefantrine. The date this was pre-
scribed was considered to be the index date of diagnosis.
Analysis
The overall crude incidence of malaria was estimated per 100,000 person years at risk (PYAR).
This was determined by totalling the number of patients with a first recording of malaria
between 2005 and 2016, and then dividing this number by the total person years of follow-up
for all patient records for this period. The start date used to calculate the total PYAR for each
participant was the latest of:
• The date the individual registered with their current general practice
• The date the practice reached AMR
• The date the practice reached ACU
• The 1st of January 2005
The end date used to calculate the total PYAR for each participant was the earliest of:
• The date the individual transferred to a different practice to the one included in the analysis.
• The date of death recorded in the practice.
Fig 1. An algorithm summarising how malaria cases were identified within THIN database. THIN: The Health Improvement Network, ACT:
Artemesinin-based combination therapy. To minimise the effect of miscoding a diagnosis of malaria for a pre-travel malaria advice consultation, those
with a prescription for a travel vaccination issued on the same day as a malaria recording were excluded (S1 Table).
https://doi.org/10.1371/journal.pone.0210040.g001
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• The last date the practice contributed data to THIN.
• The index date of diagnosis in those who have malaria
• The 31st of December 2016
Crude incidence rates by calendar year, age group (<10, 10–19, 20–29, 30–39, 40–49, 50–
59, 60–69, 70–79, 80–89 and>90 years), sex (male and female), level of social deprivation
(Townsend Score; a measure which incorporates unemployment, car ownership, home owner-
ship and household overcrowding to calculate area-level deprivation. The score ranges from 1
to 5 with 1 being the least deprived and 5 indicating the greatest degree of deprivation) region
(based on former strategic health authority location; London, East Midlands, East of England,
North East, North West, Northern Ireland, Scotland, South Central, South East Coast, South
West, Wales, West Midlands and Yorkshire and Humber) and ethnicity (Grouped into the
2001 UK census 5 category classification: White, Black, Asian, Other and Mixed) were also
estimated by restricting the person years of follow-up to the respective category in question.
Multivariable Poisson regression analysis was carried out to explore the change in incidence
by calendar year, age group, sex, region and Townsend score mutually adjusting for the other
variables included in this model. Ethnicity was not included in the model as the data quality
was poor with missing data in 40% of cases. To fit the Poisson model to calculate a rate ratio,
the coefficients were exponentiated with person-time specified as the exposure.
Additionally a sensitivity analysis was conducted to take into account multiple episodes of
malaria in the same individual. It was considered an individual had an additional episode of
malaria if they had a diagnostic Read code for malaria at least three months after the previous
recording. In these individuals, the start date used to calculate PYAR commenced three
months after the date of the previous event as they were not considered to be at risk during
that three month period.
All statistical analyses were carried out using Stata version 14 [20].
Comparison with national surveillance data
Data on the number of malaria cases imported to the United Kingdom from 2005 to 2016 by
UK region was obtained from the PHE Travel and Migrant section. In the absence of an equiv-
alent denominator for PYAR to estimate incidence for PHE data, we compared the number of
cases by year and UK region as a proportion of the total number of cases for each dataset from
2005 to 2016 to describe the variation in the number of cases identified over time, and their
geographical spread in THIN compared to those notified to PHE.
Ethics
THIN data collection has been approved by the South East NHS Multicentre Research Ethics
Committee. Scientific approval for this study was obtained from the IMS Heath Scientific
review committee in 2016 (ref: SRC 16THIN056).
Results
A total of 1,806 individuals with a first diagnosis of malaria were identified in THIN between
2005 and 2016, with 1,474 cases included in the final analysis after excluding those with a code
for a travel vaccination on the index date of diagnosis or were missing sociodemographic data.
A summary of the number of cases identified at each stage of the algorithm is shown in (Fig 2).
The incidence of recorded malaria followed a decreasing trend dropping from a rate of 3.33
in 2005 to 1.36 cases per 100,000 person years at risk in 2016 (Fig 3). The incidence was higher
Imported malaria in the UK
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in those aged 20 to 69 compared to those less than 20 years or more than 70 years of age
(Table 1). Men experienced a higher rate of recorded malaria than women (IRR: 0.72 (95% CI
0.65–0.80), incidence per 100,000 PYAR; men 2.57, women 1.81). General Practices in London
and the East of England had the highest incidence (6.15 and 2.51 per 100,000 PYAR respec-
tively), while practices in Northern Ireland were 89% less likely to have a recording of malaria
compared to London (IRR: 0.11 (95% CI 0.07–0.18), incidence per 100,000 PYAR: 0.63)
(Table 1, S1 Fig). Greater deprivation was associated with a higher recording of malaria com-
pared to those who were less deprived (IRR: 1.86 (95% CI 1.54–2.25), incidence per 100,000
PYAR; most deprived: 3.29, least deprived: 1.48).
Ethnicity was poorly recorded in THIN with missing data on 40% of the cases included in
the analysis (Table 1). Amongst those with a recording of ethnicity, those who identify as black
had the highest incidence while those who identified as white had the lowest (56.14 and 1.40
per 100,000 PYAR respectively). Those with unrecorded ethnicity data had a similar rate as
those who identified as white (1.38 vs 1.40 per 100,000 PYAR).
Fig 2. Number of cases identified in THIN from 2005 to 2016. THIN: The Health Improvement Network, ACT: Artemesinin-
based combination therapy.
https://doi.org/10.1371/journal.pone.0210040.g002
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The sensitivity analysis looking at multiple episodes within the same individual identified
nine individuals with two episodes and one individual with more than two episodes of
recorded malaria within the study period. Including these episodes in the analysis had no sig-
nificant effect on the results.
Comparison with national surveillance data
There were a total of 18,833 cases of malaria identified by PHE through the MRL and HPZone
between 2005 and 2016. Comparing the proportion of cases identified by each dataset per year,
there was a proportionately larger number of cases identified in THIN between 2005 and 2009
compared to PHE and a proportionately smaller number of cases in THIN for more recent
years (2014 to 2016) (Fig 4A). In terms of region, there was a larger representation of cases
from London in PHE (57%) compared to THIN (32%) (Fig 4B).
Discussion
This study showed that the incidence of malaria recordings in primary care significantly
decreased between 2005 and 2016. Adults of working age were three times as likely to have a
diagnosis of malaria compared to children and older adults. Men were 28% more likely to have
a diagnosis of malaria compared to women. London had the highest incidence of malaria in
the UK and those who were most deprived were 86% more likely to be diagnosed with malaria
compared to those who were least deprived.
Findings of this study were similar to other data from the UK [2, 21], however the rate of
decline in the number of cases was more pronounced compared to data from the national
review for malaria, where annual case numbers have remained stable over the last 10 years [2].
Fig 3. Malaria incidence in THIN, 2005 to 2016. THIN: The Health Improvement Network, PYAR: Person Years at Risk.
https://doi.org/10.1371/journal.pone.0210040.g003
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Table 1. Incidence of malaria recordings in THIN by calendar year, age, sex, region, Townsend score and ethnicity.
Number of cases PYAR
(100,000)
Incidence Unadjusted IRR
(95% CI)
Adjusted† IRR
(95% CI)
Year
2005 175 52.50 3.33 Baseline
2006 178 54.81 3.25 0.97 (0.79–1.20) 0.97 (0.79–1.19)
2007 155 57.14 2.71 0.81 (0.66–1.01) 0.81 (0.65–1.01)
2008 151 58.95 2.56 0.77 (0.62–0.96) 0.77 (0.62–0.95)
2009 130 59.80 2.17 0.65 (0.52–0.82) 0.65 (0.51–0.81)
2010 127 59.59 2.13 0.64 (0.51–0.80) 0.62 (0.50–0.78)
2011 134 61.20 2.19 0.66 (0.52–0.82) 0.64 (0.51–0.80)
2012 83 62.42 1.33 0.40 (0.31–0.52) 0.39 (0.30–0.51)
2013 124 61.10 2.03 0.61 (0.48–0.77) 0.59 (0.47–0.74)
2014 93 57.68 1.61 0.48 (0.38–0.62) 0.48 (0.38–0.62)
2015 68 49.97 1.36 0.41 (0.31–0.54) 0.43 (0.33–0.57)
2016 56 41.27 1.36 0.41 (0.30–0.55) 0.44 (0.32–0.60)
Total 1,474 676.43 2.18
Age
Less than 10 years 79 70.44 1.12 Baseline
10 to 19 years 104 73.08 1.42 1.27 (0.95–1.70) 1.32 (0.98–1.77)
20 to 29 years 249 87.46 2.85 2.54 (1.97–3.27) 2.50 (1.94–3.22)
30 to 39 years 323 96.89 3.33 2.97 (2.32–3.80) 2.81 (2.20–3.60)
40 to 49 years 326 101.02 3.23 2.88 (2.25–3.68) 2.92 (2.28–3.74)
50 to 59 years 213 84.06 2.53 2.26 (1.75–2.92) 2.43 (1.88–3.15)
60 to 69 years 120 71.45 1.68 1.50 (1.13–1.99) 1.69 (1.27–2.25)
70 to 79 years 46 50.66 0.91 0.81 (0.56–1.16) 0.91 (0.64–1.31)
80 to 89 years 9 30.53 0.29 0.26 (0.13–0.52) 0.30 (0.15–0.60)
90 years and older 5 10.85 0.46 0.41 (0.17–1.01) 0.51 (0.21–1.25)
Sex
Male 846 329.05 2.57 Baseline
Female 628 347.37 1.81 0.70 (0.63–0.78) 0.72 (0.65–0.80)
Region
London 474 77.10 6.15 Baseline
East Midlands 25 13.74 1.82 0.30 (0.20–0.44) 0.29 (0.20–0.44)
East of England 95 37.80 2.51 0.41 (0.33–0.51) 0.45 (0.36–0.56)
North East 27 13.62 1.98 0.32 (0.22–0.48) 0.32 (0.22–0.48)
North West 80 59.40 1.35 0.22 (0.17–0.28) 0.24 (0.19–0.30)
Northern Ireland 17 27.14 0.63 0.10 (0.06–0.17) 0.11 (0.07–0.18)
Scotland 164 97.51 1.68 0.27 (0.23–0.33) 0.30 (0.25–0.36)
South Central 169 79.79 2.12 0.34 (0.29–0.41) 0.41 (0.34–0.49)
South East Coast 140 74.18 1.89 0.31 (0.25–0.37) 0.37 (0.31–0.45)
South West 73 60.50 1.21 0.20 (0.15–0.25) 0.23 (0.18–0.29)
Wales 71 68.32 1.04 0.17 (0.13–0.22) 0.20 (0.15–0.25)
West Midlands 126 54.58 2.31 0.38 (0.31–0.46) 0.42 (0.34–0.51)
Yorkshire & Humber 13 12.75 1.02 0.17 (0.10–0.29) 0.17 (0.10–0.29)
Townsend Score
(Least Deprived) 1 218 147.02 1.48 Baseline
2 204 132.21 1.54 1.04 (0.86–1.26) 1.03 (0.85–1.25)
3 290 127.94 2.27 1.53 (1.28–1.82) 1.39 (1.16–1.66)
(Continued)
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The lack of a denominator in our comparison of THIN and PHE data meant that variations
over time could either reflect changes in the number of cases identified; or changes in the
number of individuals where the cases derived from. Therefore the more pronounced decline
in THIN could partly be due to the improvement in data quality with regards to the complete-
ness of PHE data. Since 2013, cases reported to the PHE case management database (HPZone)
supplemented the cases identified in the MRL dataset. In addition, the number of cases identi-
fied in THIN may be underestimated for 2016 since not all practices contributed data for that
year, further contributing to the declining trend. Despite this, it is likely that our findings
reflect a true decline in the number of cases since 2005. Decreasing global malaria incidence
[1], decreased transmission of malaria in West Africa, where most cases in the UK are acquired
and changing chemoprophylaxis usage have been suggested as possible factors contributing to
the decline [22, 23].
Similar to data from national and European surveillance [2, 24], men were more likely to
present with malaria than women. Previous studies have suggested that gender differences in
attitudes towards seeking pre-travel health advice [25], poorer adherence to malaria chemo-
prophylaxis [26], increased risk taking behaviour and travel to more remote areas where the
risk of contracting malaria is higher may account for the male predominance in the number of
malaria cases [27]. On the other hand, other studies have shown no gender differences in che-
moprophylaxis uptake and adherence [28] and suggest that host factor differences resulting in
increased attractiveness to mosquitoes may be responsible for the higher rate of malaria in
men [26]. Although both, behavioural and biological host factors may be contributory, the
main reason for the difference is likely due to the number of individuals who travel as between
2014 and 2016, 17% more men travelled to malaria endemic areas from the UK than women
[29]. Similarly, age differences in malaria rates may also reflect UK travel patterns [29].
Although we were unable to adjust for ethnicity in our analysis due to a large amount of
missing data, the trends in the rates of recordings where data were available was comparable
with other UK data, showing higher rates in ethnic minorities (Black, mixed, Asian and other,
respectively) compared to those who were White[2, 21]. Additionally, those with missing eth-
nicity data had a similar rate of malaria recording in THIN as those who were white suggesting
Table 1. (Continued)
Number of cases PYAR
(100,000)
Incidence Unadjusted IRR
(95% CI)
Adjusted† IRR
(95% CI)
4 344 111.25 3.09 2.09 (1.76–2.47) 1.82 (1.53–2.16)
(Most deprived) 5 248 75.40 3.29 2.22 (1.85–2.66) 1.86 (1.54–2.25)
Missing 170 82.61 2.06 1.39 (1.14–1.70) 1.15 (0.94–1.42)
Ethnicity
Black 432 7.70 56.14 - -
White 312 220.00 1.40 - -
Asian 114 13.00 8.86 - -
Other 13 4.60 2.83 - -
Mixed 20 2.40 8.51 - -
Missing 592 430.00 1.38 - -
Total 1,483ⁱ 677.70 2.19 - -
THIN, The Health Improvement Network; PYAR, Person Years at Risk; CI, Confidence Interval; IRR, Incidence rate ratio.
†IRR adjusted for year, age, sex, region and Townsend score. IRR was not adjusted for ethnicity due to a large amount of missing data (40% missing).
ⁱThe total includes the 9 cases with missing demographic information.
https://doi.org/10.1371/journal.pone.0210040.t001
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that the majority of those with missing data were white. Furthermore, those diagnosed with
malaria could be more likely to have their ethnicity recorded compared to those who are not,
resulting in an inflated value for the incidence rate amongst ethnic minorities. Also, given that
ethnic minority populations are more likely to be found in London and are more likely to
experience deprivation [30, 31], ethnicity may account for the higher incidence of malaria in
London and in those who were most deprived.
Fig 4. Comparison of the proportion of total malaria cases identified by PHE and THIN from 2005 to 2016. (A) Per year, and (B) by
UK region.
https://doi.org/10.1371/journal.pone.0210040.g004
Imported malaria in the UK
PLOS ONE | https://doi.org/10.1371/journal.pone.0210040 December 31, 2018 10 / 14
Use of EHRs for malaria research could provide a complementary role to data obtained
through passive surveillance. The characteristics of each data source and their respective
strengths and limitations are summarised in (Table 2). For THIN, the large number of individ-
uals included in the analysis allowed us to accurately compare primary care incidence esti-
mates by age, sex, gender, region, socioeconomic status and calendar year. Additionally, the
use of routinely collected prospective data to estimate incidence potentially captured cases not
reported in surveillance based incidence estimates, since it relies on clinicians recording a
diagnosis of malaria regardless of whether it had been notified to Public Health England or
MRL. It also resulted in a more accurate estimation of the geographic distribution of cases
since the centralised reporting site for MRL make it less sensitive to cases resident outside of
London [6]. On the other hand, relying on clinician recording of the diagnosis also meant that
it was difficult to look at the incidence of malaria by parasite species since the species of
malaria were rarely recorded. Moreover, although our algorithm captured cases without a
diagnostic code for malaria by looking at other variables such as treatment and investigations
and excluded those with a code for a travel related vaccination, there still remains a risk of
some misclassification if a diagnosis of malaria was not considered. Furthermore, our use of
GP records for the analysis of incidence meant that our findings are restricted to those
Table 2. summarising the characteristics, strengths and limitations of using PHE data and primary care EHR (THIN) data.
PHE THIN
Data source Passive surveillance through MRL (supplemented by HPZone
since 2013) [2]
Primary care electronic health records
Case definition for
malaria case
Parasitological confirmation of diagnosis by blood film or tissue
histology. Cases treated presumptively or diagnosed by other
methods (e.g. antigen based) are not included [34].
Indicated by diagnostic codes for malaria, or a combination of
investigation and treatment codes
Coverage and
representativeness of
sample
UK population [2] Coverage of around 6% of the UK population and has been shown
to be broadly representative of the UK population [15]
Data quality and type of
data available
Data collected solely for malaria surveillance capturing important
variables related to malaria e.g. parasite species, ethnicity, travel
history, chemoprophylaxis and treatment.
Primary use of EHR’s is patient management and data will reflect
only those relevant to patient care.
Good quality of recordings for investigations and prescriptions.
Poor quality of data on parasite species, ethnicity and travel history.
Timeliness of annual
reporting
Annual data is published six months after the end of the year (e.g.
Annual report for 2016 available online August 2017)
Data is collected from participating general practices every three
months by the data provider (IMS health/IQVIA), who then provide
access to the data for researchers through a license.
Strengths • Most complete source of information about malaria in the UK
• Data is collected in a standardised way
• High specificity for identifying malaria cases
• Does not rely on notification of cases.
• Availability of data on malaria investigation and treatment allows
cases to be identified even when a diagnosis is not coded.
• Data is available on the sequence of care prior to a diagnosis of
malaria, allowing investigation into potential missed
opportunities for diagnosis and treatment.
• More accurate estimation of geographical distribution of cases
• Can explore associations for contracting malaria in variables not
captured by the PHE malaria form
Limitations • Relies on notification—only 56% of cases captured by
surveillance system
• Data available is restricted to what is collected in the Patient
report/referral form
• Centralised reporting site—More sensitive to cases resident in
London [6]
• Miscoding, misclassification and misdiagnosis—These can be
minimised by using recorded data from a consultation to exclude
common coding errors (e.g. Miscoding malaria for malaria
prophylaxis can be excluded by identifying prescriptions which
are prescribed prior to travel)
• Does not capture those not registered with a GP
• Relies on practices using a specific IT system (INPS vision).
Regional variation in the transition of practices to other IT
systems can affect the representativeness of the sample over time.
https://doi.org/10.1371/journal.pone.0210040.t002
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registered with a general practitioner. Using an additional data source from secondary care
(Hospital Episode Statistics, HES) could have resulted in additional information on parasite
species and identified further cases not recorded in THIN [32]. However, the limited number
of practices in THIN with linkage to HES (23% of practices) and the lack of HES-linked data
for practices outside England would have restricted the number of individuals included in the
study [33]. Despite this, future research on the subset of individuals with HES linked data
could provide insight into the levels of recording in both settings. Finally, the number of
malaria recordings is not a true reflection of incidence since only those who travel are at risk of
contracting malaria, however, in the absence of reliable data regarding travel in THIN, includ-
ing all individuals when looking at the rate of malaria recordings allows us to explore trends
over time and compare with surveillance data which also uses population data [2, 24].
This is the first study, to the best of our knowledge, which has explored malaria recordings
over time using UK primary care data. The comparability of our findings to that from other
UK data sources supports the use of this routinely collected data source for further research.
Since the majority of previous malaria related research is retrospective [35], the routine
recording in primary care datasets can allow prospective evaluation of the sequence of care
prior to a diagnosis amongst the cases identified in this study. Given that prompt diagnosis
and treatment of malaria remains a challenge in primary care [36], future research can use pri-
mary care data to identify missed opportunities for diagnosis and explore factors associated
with it. Additionally, the improved geographic information on the distribution of cases can
help with resource allocation and delivery of malaria prevention and treatment services.
Conclusion
There has been a decrease in the number of malaria recordings in UK primary care over the
past decade. This decrease exceeds the rate of decline reported in national surveillance data;
however there are similar associations with age, sex and deprivation. Improved geographic
information on the distribution of cases and the potential for automation of case identification
suggests that EHRs could provide a complementary role for investigating malaria trends over
time.
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